title: Who receives long-acting antipsychotic medications?
authors.forename: William M
authors.initials: WM
authors.lastname: Glazer
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage*; D044383:Black People / Q000523:psychology*; D003617:Dangerous Behavior; D004363:Drug Utilization / Q000706:statistics & numerical data; D005476:Fluphenazine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006801:Humans; D011287:Prejudice; D012559:Schizophrenia / Q000188:drug therapy* / Q000208:ethnology*; D012959:Socioeconomic Factors; D014481:United States; D044465:White People / Q000523:psychology*; D001741:Black or African American
chemical_list: D014150:Antipsychotic Agents; C011825:fluphenazine depot; D005476:Fluphenazine